DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $94,003,000 | +4.9% | 1,207,643 | +5.6% | 0.11% | -0.9% |
Q3 2016 | $89,650,000 | -21.4% | 1,143,635 | +1.3% | 0.11% | -23.6% |
Q2 2016 | $114,006,000 | +7.4% | 1,128,773 | +0.9% | 0.14% | +4.3% |
Q1 2016 | $106,171,000 | -0.7% | 1,119,240 | -2.8% | 0.14% | +0.7% |
Q4 2015 | $106,966,000 | +10.1% | 1,151,657 | +1.0% | 0.14% | +4.6% |
Q3 2015 | $97,193,000 | -7.3% | 1,140,629 | -6.9% | 0.13% | +0.8% |
Q2 2015 | $104,820,000 | +7.9% | 1,224,681 | +7.1% | 0.13% | +2.4% |
Q1 2015 | $97,106,000 | -2.5% | 1,143,769 | -1.6% | 0.13% | -3.8% |
Q4 2014 | $99,591,000 | +15.3% | 1,161,949 | +2.2% | 0.13% | +9.1% |
Q3 2014 | $86,399,000 | -8.4% | 1,137,129 | -5.1% | 0.12% | -4.7% |
Q2 2014 | $94,309,000 | +13.9% | 1,197,884 | +8.5% | 0.13% | +5.8% |
Q1 2014 | $82,834,000 | -0.3% | 1,104,459 | +2.6% | 0.12% | -2.4% |
Q4 2013 | $83,070,000 | -27.2% | 1,076,038 | -34.6% | 0.12% | -34.6% |
Q3 2013 | $114,136,000 | +23.0% | 1,646,510 | +12.3% | 0.19% | +13.3% |
Q2 2013 | $92,790,000 | – | 1,465,873 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |